Xencor (XNCR) Capital Expenditures (2013 - 2026)

Xencor (XNCR) reported Capital Expenditures of $610000.0 for Q1 2026, down 57.76% year-over-year from $1.4 million in Q1 2025, and down 46.49% quarter-over-quarter from $1.1 million in Q4 2025.

Xencor (XNCR) Capital Expenditures (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Capital Expenditures data on file, last reported at $610000.0 in Q1 2026.

  • Capital Expenditures for Q1 2026 came in at $610000.0, down 57.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 68.74% YoY), and the FY2025 annual result was $3.2 million, down 48.34% from the prior year.
  • Capital Expenditures slipped to $610000.0 in Q1 2026 per XNCR's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $14.1 million in Q3 2022 and troughed at $132000.0 in Q1 2024.
  • A 5-year average of $3.9 million and a median of $1.7 million in 2024 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2024 and 2025: Capital Expenditures slumped 98.78% in 2024, then jumped 993.94% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $10.0 million in 2022, then tumbled by 90.17% to $980000.0 in 2023, then jumped by 69.8% to $1.7 million in 2024, then slumped by 31.49% to $1.1 million in 2025, then tumbled by 46.49% to $610000.0 in 2026.
  • Business Quant data shows XNCR's Capital Expenditures at $610000.0 in Q1 2026, $1.1 million in Q4 2025, and $183000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Xencor 953.38 Mn 878.64 Mn - 610,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 610,000.00
Mar 31, 2026 610,000.00
Dec 31, 2025 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 183,000.00
Sep 30, 2025 183,000.00
Jun 30, 2025 383,000.00
Jun 30, 2025 383,000.00
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.66 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.28 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 3.03 Mn
Jun 30, 2024 3.03 Mn
Mar 31, 2024 132,000.00
Mar 31, 2024 132,000.00
Dec 31, 2023 980,000.00
Dec 31, 2023 980,000.00